Literature DB >> 11283800

Severe babesiosis in Long Island: review of 34 cases and their complications.

J C Hatcher1, P D Greenberg, J Antique, V E Jimenez-Lucho.   

Abstract

Thirty-four consecutive patients were hospitalized with diagnosis of severe Babesia infection over the course of 13 years. The average time from onset of symptoms to diagnosis was 15 days. When compared with uninfected febrile control patients, affected patients complained significantly more often of malaise, arthralgias and myalgias, and shortness of breath (P<.05), and they more often had thrombocytopenia and abnormal liver function (P<.05). Forty-one percent of patients with Babesia developed complications such as acute respiratory failure, disseminated intravascular coagulation, congestive heart failure, and renal failure. Analysis of data revealed that complicated babesiosis was more commonly associated with the presence of severe anemia (hemoglobin level <10 g/dL; P=.01) and higher parasitemia levels (>10%; P=.08). Patients were treated with a combination of drugs that included clindamycin, quinine, atovaquone, or azithromycin. Despite treatment, parasitemia persisted for an average of 8.5 days (range, 3--21 days). Exchange transfusion was performed for 7 patients, and it effectively reduced the high levels of parasitemia. Three patients died. Improved outcomes may result with prompt recognition and treatment of babesiosis.

Entities:  

Mesh:

Year:  2001        PMID: 11283800     DOI: 10.1086/319742

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  71 in total

Review 1.  Antiparasitic agent atovaquone.

Authors:  Aaron L Baggish; David R Hill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Tick-borne disease (babesiosis).

Authors:  Hanish Jain; Garima Singh; Rahul Mahapatra
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-08-24

3.  79-year-old man with fever, malaise, and jaundice.

Authors:  Lisa M Baumann Kreuziger; Alfonso J Tafur; Rodney L Thompson
Journal:  Mayo Clin Proc       Date:  2009-03       Impact factor: 7.616

4.  Severe Babesia microti infection presenting as multiorgan failure in an immunocompetent host.

Authors:  Juan G Ripoll; Mahrukh S Rizvi; Rebecca L King; Craig E Daniels
Journal:  BMJ Case Rep       Date:  2018-05-30

5.  Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis.

Authors:  Neeharik Mareedu; Anna M Schotthoefer; Jason Tompkins; Matthew C Hall; Thomas R Fritsche; Holly M Frost
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

6.  A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse.

Authors:  Jacob E Lemieux; Alice D Tran; Lisa Freimark; Stephen F Schaffner; Heidi Goethert; Kristian G Andersen; Suzane Bazner; Amy Li; Graham McGrath; Lynne Sloan; Edouard Vannier; Dan Milner; Bobbi Pritt; Eric Rosenberg; Sam Telford; Jeffrey A Bailey; Pardis C Sabeti
Journal:  Nat Microbiol       Date:  2016-06-13       Impact factor: 17.745

7.  Endemic babesiosis in another eastern state: New Jersey.

Authors:  Barbara L Herwaldt; Paul C McGovern; Michal P Gerwel; Rachael M Easton; Rob Roy MacGregor
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

8.  Update on babesiosis.

Authors:  Edouard Vannier; Peter J Krause
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-27

9.  Transfusion-associated babesiosis after heart transplant.

Authors:  Joseph Z Lux; Don Weiss; Jeanne V Linden; Debra Kessler; Barbara L Herwaldt; Susan J Wong; Jan Keithly; Phyllis Della-Latta; Brian E Scully
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

10.  Babesiosis as a rare cause of fever in the immunocompromised patient: a case report.

Authors:  Daniel A Nelson; Joanna K Bradley; Rajiv Arya; Monica Ianosi-Irimie; Andreia Marques-Baptista; Mark A Merlin
Journal:  Cases J       Date:  2009-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.